Nothing Special   »   [go: up one dir, main page]

Streptokinase Group

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 16
At a glance
Powered by AI
Streptokinase is a protein secreted by streptococci bacteria that can activate plasminogen and dissolve blood clots. It has applications in treating myocardial infarction, pulmonary embolism, and deep vein thrombosis.

Streptokinase is a protein that is secreted by certain bacteria. It binds to and activates plasminogen in the blood, converting it to plasmin which breaks down blood clots.

The main indications for use of streptokinase include acute myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis, and embolism.

Streptokinase

Streptokinase:
Is a protein secreted by several
streptococci, it can bind &
activate human plasminogen to
convert to plasmin.

: Generic name
.Streptokinase

:Brand (trade) name


Kabikinase, Streptas ( names
registered medication in Saudi Arabia
.according to FDA)

: Therapeutic class
.Thrombolytic enzyme

: Pharmacologic class
. Tissue Plasminogen Activator

Pharmacology:
Converts plasminogen to the enzyme
plasmin, which aids in dissolution of
blood clots.

:Available forms
The only available form is powder.

:Administration
.
IV ( intravenous route )-1
.IC ( intracoronary route )-2
:Action
Dissolve clot that have formed in blood
.vessels

Storage/Stability:
Store unopened vials at controlled room
temperature (59 to 86F). Use
reconstituted solution immediately or
within 8 h if stored at
36 to 46F. Discard any unused

Pharmacokinetics

Metabolism:
No metabolites identified.

Elimination:
Streptokinase is cleared by the liver.
The half life is approximately 23 .

:Indications & usage

. AMI- 1
lysis of intracoronary thrombi improvement of
ventricular function, and reduction of mortality
associated with acute MI; reduction of infarct size and
.CHF associated with acute MI
.
Pulmonary Embolism-2

.DVT-3
acute, extensive thrombi of the deep veins (eg, those
involving the popliteal vessels); lysis of acute arterial
thrombi and emboli; alternative to surgical revision for
clearing totally or partially occluded arteriovenous
cannula when acceptable flow cannot be achieved.

Dosage and Administration

Acute MI (Adults):
IV infusion Administer ASAP after symptom onset
(greatest benefit when administered within 4 h, but
benefit has been reported up to 24 h). Infuse a total
dose of 1,500,000 units within 60 min.
Intracoronary infusion Administer 20,000 units by
bolus followed by 2000 units/min for 60 min (total
dose, 140,000 units).

PE , DVT, Arterial Thrombosis, or Embolism


(Adults):
IV infusion Administer ASAP after onset of thrombotic
event, preferably within 7 days. A loading dose of
250,000 units infused into a peripheral vein over 30
minutes has been found appropriate in over 90% of

:Nursing consideration

.Monitor Coagulation profile 1


checking ECG & Vital signs-2
Be aware if patient has had either recent-3
streptococcal infection or recent treatment with
.streptokinase, higher loading dose may be necessary
Check hypersensitivity reactions, give 100 unit-4
intradermal, as ordered; wheal & flare response within
.20 minutes means patient is probably allergic
.Notify doctor immediately if hypersensitivity occur-5
Keep corticosteroids and aminocaproic acid available -6
.to treat allergic reaction and bleeding

Contraindications:
1-Active internal bleeding.
2- Recent cerebrovascular accident
(within 2 months).
3- Intracranial or intraspinal surgery
4- Severe uncontrolled hypertension.

Side Effect:

1- Bleeding.
2-Allergic reaction.
3-Sever kidney disease.
4-Dameg to the blood vessels
and others.

Notify the doctor immediately if the


patient complain of any of the
following:
1-Blurred Vision.
2-Dizziness.
3-Fever.
4-Sweating.

Streptokinas
e:
Aminocaproic
acid.

Thank you

You might also like